Analysis
Pure-play InsurTech companies raised $1.666 billion across 32 disclosed deals between August 2025 and July 2026, according to sector-tracking data compiled by New Market Pitch. Two companies account for more than half of it.
- Alan -- roughly €480 million Series G at a $6.3 billion valuation, about a third of the category's entire disclosed total on its own.
- Corgi -- three separate raises adding up to $374 million, another 22% of the total.
What's Actually Being Funded
Alan, a French health and benefits insurer, has built its business on replacing the incumbent group-benefits providers that dominate European corporate insurance -- a category where switching costs are high and incumbents (AXA, Allianz, Generali) have decades of actuarial data advantage. Its ability to raise at a $6.3 billion valuation despite that competitive moat suggests investors believe a digital-native underwriting and claims experience is enough of a wedge to win share regardless.
Corgi, by contrast, has raised three separate rounds inside roughly eight months, a cadence that reads as either exceptional execution or a company burning capital faster than a typical insurance underwriter should need to -- insurance businesses generally require large reserves relative to premium volume, which makes repeated capital raises a normal feature of scaling, not necessarily a red flag on its own.
The Concentration Problem
Thirty other disclosed deals split the remaining 45% of category capital, meaning the median InsurTech round in this window was well under $20 million -- a funding environment where most companies in the category are operating on seed-to-Series-A budgets while two players absorb growth-stage capital at ten times that scale. That is a more extreme version of the power-law distribution venture investors generally expect, and it means InsurTech, unlike more evenly distributed categories such as fintech infrastructure, is closer to a winner-take-most market at the funding level well before any company has proven winner-take-most economics at the customer level.
What Founders Should Take From This
For a founder pitching an InsurTech seed or Series A right now, the practical read is that generalist growth investors have largely already picked their category leaders and are deploying follow-on capital rather than searching for new entrants. That doesn't close the category to new founders -- insurance is large enough that a specialist niche (parametric coverage, a specific vertical like climate risk, or embedded insurance for a particular platform) can still attract seed capital on its own merits -- but it does mean the pitch needs to explicitly explain why the company isn't competing head-on with Alan or Corgi's now well-capitalized playbooks, because a generalist fund comparing your deal against theirs will notice the capital gap immediately.
